Murray Alzheimer Research and Education Program (MAREP)
Alzheimer's disease and related dementias are a world-wide phenomenon that ignores social class and national boundaries. As age is the greatest risk factor for the development of Alzheimer's disease, more and more individuals will be diagnosed with Alzheimer's disease and related dementias as the population ages.
At the present time there is no known cause or cure for Alzheimer's disease. As the search for an effective treatment continues, it is important that people who have Alzheimer's disease or a related dementia receive the best care possible and are provided with support and opportunities to live meaningful lives.
To implement effective approaches for care of people living with Alzheimer's disease and related dementias, contemporary research findings need to be brought to the attention of all partners in care including people with dementia, family members and friends, health care professionals, and so forth. The converse is true as well in that effective approaches to care need to be brought to the attention of researchers.
The Murray Alzheimer Research and Education Program (MAREP) is an innovative program that adopts a partnership approach and integrates research and educational activities in an effort to improve dementia care practices in Canada and around the world. Although MAREP's research projects are funded by research grants, all of its knowledge translation activities are funded through donations and charitable gifts from individuals and groups: find out how you can support our programs.
More information is available for people living with dementia, care partners, and anyone else affected by dementia in our Innovations Newsletter, published three times per year, the Dementia Weekly News Service, our blog, and the educational tools and training and workshops we offer.
- Feb. 12, 2018
Exosomes are vesicles created by the cell to transport components through the body. The particular type of exosome that is creating excitement in Alzheimer’s research is exosomes that deliver anti-inflammatory agents to the brain. Celltex Therapeutics Corp. and Texas A&M University Health Science Center College of Medicine Institute for Regenerative Medicine have teamed up to pursue research on how to utilize exosomes to reduce inflammation in the brain.
- Feb. 12, 2018
A study conducted with over 4000 older adults (aged 60+) by Yale University found that positive beliefs on aging had a significant impact on the development of dementia. They found that participants who had positive beliefs on aging reduced their risk of dementia by 44 percent, and that those who had a genetic predisposition for dementia the risk almost halved. Dr. Levy and her colleagues recruited 4765 “dementia free” adults, with an average age of 72.
- Feb. 12, 2018
Professors, Matthew Macauley and John Klassen, from the University of Alberta are investigating how glycomics, the study of carbohydrates (sugars) may be linked to Alzheimer’s disease. Determining how the glycans (sugars) interact with a protein known as CD33, which has strong implications in Alzheimer’s disease, may create potential therapies. The researchers explain that receptors for sugars in microglia (white blood cells found in the brain) can serve as an indicator of who will develop Alzheimer’s disease.
- July 25, 2017
Last month, Bill C-233, an Act respecting a national strategy for Alzheimer’s disease and other dementias, sponsored by the Honourable Rob Nicholson and Rob Oliphant, was passed. Canada will be the 30th country out of 194 members of the World Health Organization to implement a national dementia plan.
- June 6, 2017
Hi I am your assignment for today.
I know I am just one of many but I ask you to please take the time to know me. You see I once was also a nurse. That really doesn't matter as I am a human being. I come with an education and feeling. I am also a wife a mother, a grandmother and more. Please take the time to read my chart as you can gain much knowledge about me before you ever meet me. In it you will find my medical history, this may give you a glimpse of what to expect from me. It will tell you what is being treated now. Know full well that, that may not be my only problem.
- May 2, 2017
A Letter from the Chair
Hello, ODAG Members, Friends, and Supporters.
The last two months have been very interesting for people living with dementia. It is a time of policy changes, budget allocations and the broadening of the Council of Canadians with Disabilities to formally include people living with dementia.